Log in to save to my catalogue

Sortilin Expression Levels and Peripheral Immunity: A Potential Biomarker for Segregation between Pa...

Sortilin Expression Levels and Peripheral Immunity: A Potential Biomarker for Segregation between Pa...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2925000832

Sortilin Expression Levels and Peripheral Immunity: A Potential Biomarker for Segregation between Parkinson's Disease Patients and Healthy Controls

About this item

Full title

Sortilin Expression Levels and Peripheral Immunity: A Potential Biomarker for Segregation between Parkinson's Disease Patients and Healthy Controls

Publisher

Switzerland: MDPI AG

Journal title

International journal of molecular sciences, 2024-02, Vol.25 (3), p.1791

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Parkinson's disease (PD) is characterized by substantial phenotypic heterogeneity that limits the disease prognosis and patient's counseling, and complicates the design of further clinical trials. There is an unmet need for the development and validation of biomarkers for the prediction of the disease course. In this study, we utilized flow cytomet...

Alternative Titles

Full title

Sortilin Expression Levels and Peripheral Immunity: A Potential Biomarker for Segregation between Parkinson's Disease Patients and Healthy Controls

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2925000832

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2925000832

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms25031791

How to access this item